Global Oral Antidiabetic Drugs Market to Register $35.91 Bn Growth by 2022
Diabetes is a group of metabolic disorder characterized by the presence of high blood glucose level than normal level in an individual. The rise of blood glucose is due to inadequate insulin production, or because the body's cells do not respond properly to insulin. Diabetes is broadly characterized into two types: Insulin-dependent diabetes mellitus (type 1) and Non-insulin dependent diabetes mellitus (type 2). Various initial symptoms associated with diabetes include increasing thirst, frequent urination, fatigue, weight and muscle loss, delayed...
View full press release